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Carotid Endarterectomy Under General, but Not Local, Anaesthesia
Wijeyaratne S.M., Collins M.A., Barth J.H., Gough M.J. Eur J Vasc Endo-
vasc Surg 2009;38:262-266.
Introduction: Previous studies indicate that local (LA) rather than
general anaesthesia (GA) for carotid endarterectomy (CEA) is associated
with reflex hypertension and preservation of cerebral cytochrome oxidase
after carotid clamping. The hypothesis that LA offers protection against
ischaemic cerebral injury has been investigated by measuring ipsilateral
jugular venous neurone specific enolase (NSE: neuronal glycolytic enzyme)
and S-100B (glial cell protein) during and after CEA.
Methods: 27 patients with symptomatic carotid artery disease (70–
99% stenosis) underwent CEA, 14 under LA and 13 under GA. Jugular
venous blood samples were assayed for NSE and S-100B before carotid
clamping and at 5 min before and 5 min, 2, 4, 6, 8, 12 and 24 h after clamp
release.
Results: No neurological complications occurred. S-100B levels
were low and did not increase from baseline in either group. Pre-clamp
NSE levels were similar in both groups (LA: 17.6 (15.2–20.7) g/l, GA:
21.5 (11.3–26.2) g/l; p  0.37) but increased significantly 2 h after
clamp release in GA patients (LA: 25.5 (16.6–27.8) g/l, GA: 48.2
(31.4–61.3) g/l, p  0.05) with a significant rise from baseline in GA
patients (p  0.04).
Conclusions:CEA performed under GA is associated with greater rises
in jugular venous NSE, and hence cerebral injury, than CEA performed
under LA.
The EndovascularManagement of Penetrating Carotid Artery Injuries:
Long-term Follow-up
du Toit D.F., Coolen D., Lambrechts A., de V. Odendaal J., Warren B.L.
Eur J Vasc Endovasc Surg 2009;38:267-272.
Objectives: To review a single-centre experience with stent-graft treat-
ment of penetrating carotid artery injuries and long-term follow-up.
Methods: All stable patients with carotid artery injuries presenting
between August 1998 and February 2009 were considered for endo-
vascular treatment. Patients were selected based on clinical and radio-
logical criteria and data were prospectively collected. Follow-up was
conducted clinically, angiographically and by telephonic contact. End-
points were stroke, death and any other stent-graft-related complica-
tions.
Results: A total of 128 patients were treated, of whom only 19 were
selected for endovascular management. The recorded technical success rate
was 100%, with one early stroke and one non-stent-graft-related procedural
death. A further four patients were lost to follow-up. The remaining 14
patients had a mean follow-up of nearly 4 years. No stent-graft-related late
deaths, strokes or other complications were reported, although one instance
of late stent-graft occlusion was documented.
Conclusion: Endovascular management of penetrating carotid artery
injuries is safe and the long-term outcomes justify a more liberal application
of this technique in selected patients.
The Importance of Anatomical Suitability and Fitness for the Outcome
of Endovascular Repair of Ruptured Abdominal Aortic Aneurysm
Richards T., Goode S.D., Hinchliffe R., Altaf N., MacSweeney S., Braith-
waite B. Eur J Vasc Endovasc Surg 2009;38:285-290.
Introduction: Endovascular repair of aortic aneurysm (EVAR) has a
lower mortality than open repair. The aim of this study was to assess
mortality fromEVAR for emergency AAA repair and the impact of fitness for
operation and adverse anatomy.
Methods: One-hundred and forty two patients who had EVAR for a
ruptured AAA (80, REVAR) or a symptomatic AAA (62, SEVAR) between
1994 and 2007 in a single specialist endovascular centre were reviewed.
Fitness for surgery was assessed by Hardman’s index (age  76, loss of
consciousness, Hb  9.0, Cr  190, ischaemic ECG). CT scans were re-
viewed, compared with operative images and operation notes for adverse
anatomy. Details of perioperative complications, and outcome were re-
corded.Results:Overall mortality at 24-h, 30-days and one year were, respec-
tively: 17%, 36%, 50% for REVAR and 5%, 8%, 23% for SEVAR. Overalladverse anatomy increased 30-day mortality. Hardman’s index of three or
more increased mortality HR  2.59 (1.24–5.41), p  0.01. On Cox re-
gression Univariate analysis increasing Hardman’s index score and adverse
anatomy increased the overall mortality over time. In multivariate Cox
regression analysis (controlled for the Hardman’s index) adverse anatomy
was associated with significant increase in graft related mortality.
Conclusion: The use of EVAR is feasible in patients who present with
a ruptured or acutely symptomatic AAA. Care must be taken not to extend
anatomical or clinical guidelines.
AComparison of theMid-termResults Following the use of Bifurcated
and Aorto-uni-iliac Devices in the Treatment of Abdominal Aortic
Aneurysms
Jean-Baptiste E., Batt M., Azzaoui R., Koussa M., Hassen-Khodja R.,
Haulon S. Eur J Vasc Endovasc Surg 2009;38:298-304.
Purpose: To compare the mid-term results following the use of bifur-
cated (ABIS) and aorto-uniiliac (AUIS) endovascular devices in the treat-
ment of abdominal aortic aneurysms (AAA) in a population of patients
deemed to be at high risk for open surgery.
Material and methods: Over a 4 year period (January 2003 to
December 2007), 447 underwent elective endovascular aneurysm repair
(EVAR) using ZENITH® stent-grafts. Group I comprised patients treated
using the AUIS (n  124), and group II those receiving ABIS (n  323).
Outcomemeasures included the assisted technical success rate, perioperative
mortality, major complications, freedom from reintervention, and primary
and secondary patencies. Factors associated with mid-term clinical failures
were determined using univariate and multivariate analyses.
Results:The assisted primary technical success rate was 94% and 99% in
groups I and II respectively (p  .002). Major perioperative complications
occurred in 13 group I patients (10%) vs. 12 group II patients (4%)
(p  .005). The 30-day mortality rate was 3.2% vs.1.5% (p  0.2). TASC C
and D iliac lesions significantly increased the risk of major perioperative
complications (35% vs. 3%; OR  14.94; 95% CI: 5.75 to 38.78;
p  .0001). During the follow-up period (median 24 months), secondary
procedures were required in 11% and 5% of group I and group II patients
respectively (p  .01). Freedom from reintervention at 12, 24 and 36
months was 98%, 90%, and 85% in group I vs. 96%, 92%, and 92% in group
II (P  0.005). The primary and secondary patency rates at 3 years were 92%
vs. 98% (p  .003) and 97% vs. 99% (p  .04) for groups I and II respec-
tively. In group I, the Crossover Femoro-Femoral Bypass (CFFB) was
responsible for 3 major complications (2.4%) which occurred at 7, 12 and 57
months of follow-up. However, the use of AUIS with CFFB did not
independently increase the risk of major complications during follow-up
(HR  0.108; 95%CI: 0.007 to 1.637; p  .11, Cox proportionmodel). In
both univariate and multivariate analysis, concomitant iliac arterial occlusive
disease (IAOD) was the only significant predictor of clinical failure in study
population as a whole (OR  3.996; 95% CI: 1.996 to 7.921; p  .0001).
Conclusion: This study demonstrates that ABIS is associated with
better results than AUIS in the management of patients with AAA. Iliac
artery occlusive disease was more frequently diagnosed in the AUIS group
and this was significantly associated with a higher risk of complications, while
the crossover graft itself was not. Nevertheless, the outcomes for both
groups are encouraging in this high risk population.
Prevalence of Symptomatic and Asymptomatic Peripheral Arterial Dis-
ease and the Value of the Ankle-brachial Index to Stratify Cardiovas-
cular Risk
Ramos R., Quesada M., Solanas P., Subirana I., Sala J., Vila J., Masiá R.,
Cerezo C., Elosua R., Grau M., Cordón F., Juvinyà D., Fitó M., Isabel
Covas M., Clarà A., Ángel Muñoz M., Marrugat J., on behalf of the
REGICOR Investigators. Eur J Vasc Endovasc Surg 2009;38:305-311.
Objectives: To determine the prevalence of ankle-brachial index
(ABI)  0.9 and symptomatic peripheral arterial disease (PAD), association
with cardiovascular risk factors (CVRF), and impact of adding ABI measure-
ment to coronary heart disease (CHD) risk screening.
Design: Population-based cross-sectional survey of 6262 participants
aged 35–79 in Girona, Spain.Methods: Standardized measurements (CVRF, ABI, 10-year CHD
risk) and history of intermittent claudication (IC), CHD, and stroke were
703
